Disitamab vedotin (ADC)

• Description:

  Disitamab vedotin is an ADC consisting of a HER2-directed antibody and Monomethyl auristatin E (MMAE) . Disitamab vedotin targets HER2 protein on tumors, recognizes and penetrates cancer cells with high precision, and releases the small molecule cytotoxic drug to kill the cancer cell. The ADC is used for the study of various cancers.

• Product Name Alternative:

  RC48, Aidixi

• Reactivity:

  Human

• Applications:

  Research Grade Biosimilar

• Stability:

  Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks) . Store at -20°C 12 months. Store at -80°C long term.

• Endotoxin:

  Please contact with the lab for this information.

• Purity:

  >90% as determined by SEC.

• Form:

  Liquid

• Notes:

  For research use only. Not suitable for clinical or therapeutic use.